- Home
- ASTC vs PSTV Comparison
ASTC vs PSTV Comparison
Compare ASTC & PSTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASTC
- PSTV
- Stock Information
- Founded
- ASTC 1984
- PSTV 1996
- Country
- ASTC United States
- PSTV United States
- Employees
- ASTC N/A
- PSTV N/A
- Industry
- ASTC Biotechnology: Laboratory Analytical Instruments
- PSTV Medical/Dental Instruments
- Sector
- ASTC Industrials
- PSTV Health Care
- Exchange
- ASTC Nasdaq
- PSTV Nasdaq
- Market Cap
- ASTC 9.8M
- PSTV 10.4M
- IPO Year
- ASTC 1995
- PSTV N/A
- Fundamental
- Price
- ASTC $5.63
- PSTV $0.36
- Analyst Decision
- ASTC
- PSTV Strong Buy
- Analyst Count
- ASTC 0
- PSTV 3
- Target Price
- ASTC N/A
- PSTV $10.83
- AVG Volume (30 Days)
- ASTC 8.6K
- PSTV 64.1M
- Earning Date
- ASTC 05-13-2025
- PSTV 08-13-2025
- Dividend Yield
- ASTC N/A
- PSTV N/A
- EPS Growth
- ASTC N/A
- PSTV N/A
- EPS
- ASTC N/A
- PSTV N/A
- Revenue
- ASTC $903,000.00
- PSTV $5,206,000.00
- Revenue This Year
- ASTC N/A
- PSTV $13.26
- Revenue Next Year
- ASTC N/A
- PSTV $8.84
- P/E Ratio
- ASTC N/A
- PSTV N/A
- Revenue Growth
- ASTC N/A
- PSTV N/A
- 52 Week Low
- ASTC $5.39
- PSTV $0.16
- 52 Week High
- ASTC $12.29
- PSTV $2.31
- Technical
- Relative Strength Index (RSI)
- ASTC 43.43
- PSTV 51.37
- Support Level
- ASTC $5.50
- PSTV $0.27
- Resistance Level
- ASTC $5.73
- PSTV $0.38
- Average True Range (ATR)
- ASTC 0.27
- PSTV 0.05
- MACD
- ASTC -0.01
- PSTV 0.02
- Stochastic Oscillator
- ASTC 14.29
- PSTV 66.68
About ASTC Astrotech Corporation (DE)
Astrotech Corp is a science and technology development company. The firm invents, acquires, and commercializes technological innovations sourced from internal research, universities, laboratories, and research institutions. The 1st Detect develops, manufactures, and sells chemical analyzers for use in the airport security, military, and breath analysis markets. AgLAB develops a series of mass spectrometers for use in the agriculture market.
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).